hematopoietic system
• tamoxifen-treated mice exhibit reduction in granulocyte-monocyte progenitor (GMPs) and common myeloid progenitor (CMPs) cells and mild reduction in the total number of megakaryocyte/erythroid progenitor cells (MEP) compared with control mice
• however, tamoxifen-treated mice exhibit normal percentage of differentiated myeloid progenitor cells and erythroid progenitor cells and BFU-E and total number of colonies are rescued by re-expression of Hif1a
|
• tamoxifen-treated mice exhibit reduced common myeloid progenitors and primitive myeloid progenitors compared with control mice
|
• increased frequency in tamoxifen-treated mice
|
• long-term hematopoietic stem cells are less quiescent, prone to proliferation and more apoptotic in tamoxifen-treated mice than in control mice
|
cellular
• increased reactive oxygen species in the long-term hematopoietic stem cells of tamoxifen-treated mice
• however, treatment with N-acetyl-L-cysteine (NAC) restores reactive oxygen species
|